Skip to main navigation Skip to search Skip to main content

Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

  • C Gaggiano
  • , J Sota*
  • , A Insalaco
  • , R Cimaz
  • , M Alessio
  • , M Cattalini
  • , R Gallizzi
  • , Maggio MC
  • , G Lopalco
  • , Torre F La
  • , C Fabiani
  • , M Pardeo
  • , Olivieri AN
  • , P Sfriso
  • , C Salvarani
  • , S Grosso
  • , C Bracaglia
  • , Benedetti F De
  • , Donato Rigante
  • , L Cantarini
  • *Corresponding author

Research output: Contribution to journalArticle

Abstract

We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Issue number17 (Suppl 1)
DOIs
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • Juvenile idiopathic arthritis

Fingerprint

Dive into the research topics of 'Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.'. Together they form a unique fingerprint.

Cite this